Alkemi Capital to invest in Datar Cancer Genetics.

Synopsis

Alkemi Capital, a growth capital investment firm based in New Delhi, India, agreed to invest in Datar Cancer Genetics, a molecular oncology facility. Financial terms were not disclosed. The fundraise will happen by way of subscription to compulsorily convertible preference shares and nominal equity shares in the Company.

Principals

target

Datar Cancer Genetics

bidder

Alkemi Growth Capital

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (4)

yashojit mishra

Partner at Economic Laws Practice (ELP)

Lawyer

target

Deals

£ 2.87 B

Total Value

aditi ladha

‎Senior Associate at Economic Laws Practice (ELP)

Lawyer

target

Deals

£ 158 M

Total Value

manendra singh

Partner at Economic Laws Practice (ELP)

Lawyer

target

Deals

£ 158 M

Total Value

rajan datar

Founder at DATAR CANCER GENETICS

Manager

target

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy